ACTAVIS MID ATLANTIC FDA Approval ANDA 062949

ANDA 062949

ACTAVIS MID ATLANTIC

FDA Drug Application

Application #062949

Application Sponsors

ANDA 062949ACTAVIS MID ATLANTIC

Marketing Status

Prescription001

Application Products

001CREAM;TOPICAL100,000 UNITS/GM0NYSTATINNYSTATIN

FDA Submissions

ORIG1AP1988-06-13
LABELING; LabelingSUPPL2AP1994-07-05
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1995-07-05
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1996-08-26
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1998-06-01
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2001-10-15
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2000-01-24
MANUF (CMC); Manufacturing (CMC)SUPPL8AP2000-11-15
MANUF (CMC); Manufacturing (CMC)SUPPL9AP2001-05-30
MANUF (CMC); Manufacturing (CMC)SUPPL10AP2002-10-03

Submissions Property Types

SUPPL1Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0
SUPPL10Null0

TE Codes

001PrescriptionAT

CDER Filings

ACTAVIS MID ATLANTIC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62949
            [companyName] => ACTAVIS MID ATLANTIC
            [docInserts] => ["",""]
            [products] => [{"drugName":"NYSTATIN","activeIngredients":"NYSTATIN","strength":"100,000 UNITS\/GM","dosageForm":"CREAM;TOPICAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"NYSTATIN","submission":"NYSTATIN","actionType":"100,000 UNITS\/GM","submissionClassification":"CREAM;TOPICAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.